Please use this identifier to cite or link to this item:
Title: Bioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer
Authors: Kalogera, Eleni 
Pistos, Constantinos M. 
Provatopoulou, Xeni 
Christophi, Costas A. 
Zografos, George Constantine 
Stefanidou, Maria E. 
Spiliopoulou, Chara A. 
Athanaselis, Sotiris A. 
Gounaris, Antonia D. 
Major Field of Science: Medical and Health Sciences
Field Category: Health Sciences
Keywords: Breast cancer;Plasma androgens;Androgen glucuronides
Issue Date: 1-Apr-2016
Source: Journal of Chromatographic Science, 2016, vol. 54, no.4, pp. 583-592
Volume: 54
Issue: 4
Start page: 583
End page: 592
Journal: Journal of Chromatographic Science 
Abstract: The physiological and pathological development of the breast is strongly affected by the hormonal milieu consisting of steroid hormones. Mass spectrometry (MS) technologies of high sensitivity and specificity enable the quantification of androgens and consequently the characterization of the hormonal status. The aim of this study is the assessment of plasma androgens and androgen glucuronides, in the par excellence hormone-sensitive tissue of the breast, through the application of liquid chromatography-mass spectrometry (LC-MS). A simple and efficient fit-for-purpose method for the simultaneous identification and quantification of dehydroepiandrosterone sulfate (DHEAS), androstenedione (A4), androsterone glucuronide (ADTG) and androstane-3α, 17β-diol-17-glucuronide (3α-diol-17G) in human plasma was developed and validated. The presented method permits omission of derivatization, requires a single solid-phase extraction procedure and the chromatographic separation can be achieved on a single C18 analytical column, for all four analytes. The validated method was successfully applied for the analysis of 191 human plasma samples from postmenopausal women with benign breast disease (BBD), lobular neoplasia (LN), ductal carcinoma in situ and invasive ductal carcinoma (IDC). DHEAS plasma levels exhibited significant differences between LN, IDC and BBD patients (P < 0.05). Additionally, ADTG levels were significantly higher in patients with LN compared with those with BBD (P < 0.05).
ISSN: 1945-239X
DOI: 10.1093/chromsci/bmv190
Rights: © Oxford University Press
Type: Article
Affiliation : Hellenic Anticancer Institute 
University of Athens 
Cyprus University of Technology 
Appears in Collections:Άρθρα/Articles

Files in This Item:
File Description SizeFormat
Christophi.pdf512.78 kBAdobe PDFView/Open
CORE Recommender
Show full item record


checked on May 27, 2022


Last Week
Last month
checked on May 23, 2022

Page view(s)

Last Week
Last month
checked on May 29, 2022


checked on May 29, 2022

Google ScholarTM



Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.